Yüklüyor......
Early intervention with tafamidis provides long-term (5.5-year) delay of neurologic progression in transthyretin hereditary amyloid polyneuropathy
Transthyretin hereditary amyloid polyneuropathy, also traditionally known as transthyretin familial amyloid polyneuropathy (ATTR-FAP), is a rare, relentless, fatal hereditary disorder. Tafamidis, an oral, non-NSAID, highly specific transthyretin stabilizer, demonstrated safety and efficacy in slowin...
Kaydedildi:
| Yayımlandı: | Amyloid |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Taylor & Francis
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5359776/ https://ncbi.nlm.nih.gov/pubmed/27494299 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/13506129.2016.1207163 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|